iota Biosciences

Berkeley, United States Founded: 2017 • Age: 9 yrs Acquired By Astellas Pharma
Developer of neurodiagnostic techniques

About iota Biosciences

iota Biosciences is a company based in Berkeley (United States) founded in 2017 by Jose Carmena was acquired by Astellas Pharma in October 2020.. iota Biosciences has raised $15 million across 1 funding round from investors including Astellas Pharma, Horizons Ventures and Astellas Venture Management. iota Biosciences offers products and services including Bioelectronics Technology and Innovation Platform.

  • Headquarter Berkeley, United States
  • Founders Jose Carmena
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $15 M (USD)

    in 1 rounds

  • Latest Funding Round
    $15 M (USD), Series A

    May 04, 2018

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Astellas Pharma

    (Oct 14, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of iota Biosciences

iota Biosciences offers a comprehensive portfolio of products and services, including Bioelectronics Technology and Innovation Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops innovative bioelectronics for medical and life science applications

Provides tools for bioelectronic advancements in health research

People of iota Biosciences
Headcount 50-200
Employee Profiles 29
Employee Profiles
People
Gil Mandelbaum
General Manager, Neuro Therapies; Sr. Director, Neuromodulation & Brain-computer Interfaces
People
Cameron Esacoff
Senior Director Of Manufacturing Engineering
People
Faeze Saatchi, Ph.D.
Lead Clinical Scientist
People
Maria Diaz Bobillo
Senior Preclinical Research Medical Doctor

Unlock access to complete

Funding Insights of iota Biosciences

iota Biosciences has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $15.0M
  • First Round

    (04 May 2018)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2018 Amount Series A - iota Biosciences Valuation Horizons Ventures , Astellas Venture Management
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in iota Biosciences

iota Biosciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Astellas Pharma, Horizons Ventures and Astellas Venture Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Horizons Ventures is focused on investing in deep science and technology.
Founded Year Domain Location
-
Founded Year Domain Location
Early-stage life sciences and tech focused VC firm investing primarily in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by iota Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - iota Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Iota Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of iota Biosciences

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about iota Biosciences

When was iota Biosciences founded?

iota Biosciences was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is iota Biosciences located?

iota Biosciences is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Who is the current CEO of iota Biosciences?

Jose Carmena is the current CEO of iota Biosciences. They have also founded this company.

Is iota Biosciences a funded company?

iota Biosciences is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series A of $15M, raised on May 04, 2018.

What does iota Biosciences do?

iota Biosciences is developing neurodiagnostic techniques. The company has developed an implantable technology called neural dust which can interface directly with the central nervous system and helps in the diagnosis of internal causes of neurological diseases. The device can record electrical information, stimulate nerves and communicate with other machines through ultrasound.

What products or services does iota Biosciences offer?

iota Biosciences offers Bioelectronics Technology and Innovation Platform.

Who are iota Biosciences's investors?

iota Biosciences has 6 investors. Key investors include Astellas Pharma, Horizons Ventures, Astellas Venture Management, Bold Capital Partners, and Ironfire Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available